Table 2 |
||
|
Relationship between low serum levels of vitamin D and clinical/serological manifestations of undifferentiated connective tissue disease patients |
||
| Correlation between clinical symptoms and vitamin D insufficiency |
P value |
OD (95% CI) |
|
|
||
| Xerostomia/xerophtalmia |
0.8276 |
0.8909 (0.3768–2.107) |
| Polyarthritis |
0.4834 |
0.7621 (0.3772–1.540) |
| Skin lesion |
0.0046 |
2.987 (1.397–6.385) |
| Pleuritis |
0.0346 |
5.367 (1.078–26.719) |
| Central and peripheral nervous system manifestations |
1 |
0.8344 (0.1924–3.619) |
| Raynaud phenomenon |
0.5331 |
0.7407 (0.3178–1.726) |
| Oesophageal involvement |
0.3448 |
1.650 (0.6569–4.144) |
|
|
||
| Correlation between antibodies and vitamin D insufficiency |
||
|
|
||
| Anti-U1-ribonucleoprotein antibody |
0.0240 |
5.083 (1.286–20.094) |
| Anti-SSA antibody |
0.029 |
3.474 (1.147–10.520) |
| Anti-cyclic citrullinated peptide antibody |
0.0001 |
12.0 (3.541–42.036) |
| Anti-double-stranded DNA antibody |
0.2551 |
0.4896 (0.1751–1.369) |
| Anti-neutrophil cytoplasmic antibody |
0.2978 |
0.4024 (0.064–2.51) |
| Anti-cardiolipin antibody |
0.3728 |
1.715 (0.6535–4.501) |
| Anti-SSB antibody |
0.2945 |
0.5254 (0.1484–1.860) |
|
|
||
|
OD, Odds ratio; CI, confidence interval |
||
|
Zold et al. Arthritis Research & Therapy 2008 10:R123 doi:10.1186/ar2533 |
||
